Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
about
Impact of changing drug treatment and malaria endemicity on the heritability of malaria phenotypes in a longitudinal family-based cohort studyIncreased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adultsGenetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal.Evidence for over-dispersion in the distribution of clinical malaria episodes in children.Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodiesHeritability of the human infectious reservoir of malaria parasitesInfluence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody responseAn exhaustive, non-euclidean, non-parametric data mining tool for unraveling the complexity of biological systems--novel insights into malaria.Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructsAntibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults.Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malariaHigh number of previous Plasmodium falciparum clinical episodes increases risk of future episodes in a sub-group of individuals.Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodesCalibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine.Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.History, dynamics, and public health importance of malaria parasite resistance.Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control.Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models.Dynamical malaria models reveal how immunity buffers effect of climate variability.Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.Effect of HIV-1 infection on malaria treatment outcome in Ugandan patientsNovel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communitiesCharacterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousnessIncreasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, UgandaMeasuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity.Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, KenyaEvidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan childrenSubstantial asymptomatic submicroscopic Plasmodium carriage during dry season in low transmission areas in Senegal: Implications for malaria control and elimination.Temporal analysis of IgG antibody responses to Plasmodium falciparum antigens in relation to changing malaria epidemiology in a West African setting.Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.School-based malaria prevalence: informative systematic surveillance measure to assess epidemiological impact of malaria control interventions in the Democratic Republic of the Congo.Seasonality and heterogeneity of malaria transmission determine success of interventions in high-endemic settings: a modeling studyAge, exposure and immunityPatterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
P2860
Q28477767-183FBA02-5A86-443B-BD81-464D2E0A43A9Q30847354-D1A74B71-5FF9-4397-A268-7230D8C91C94Q31147217-9DC291AD-8FA6-4F8B-B7C7-9215CD38CD3FQ33330289-40454DD7-064A-45FD-81B0-61A7B742F72EQ33336415-1D45601E-66A5-4A87-B806-AB3244EECA75Q33548663-1EC56FDD-F919-4490-B61E-EA9FDDFA55CEQ33627561-8C823125-BF6B-4A35-B440-DD127CC9B299Q33944265-ABB128D0-0A73-4A24-964C-F8FB9B59D332Q34017806-591B5F0D-4181-4A4E-B158-4E3FB8C8D500Q34023255-9524DAA7-FA68-4B80-809F-C24B5BB73612Q34092432-728BE2AC-33A1-4480-97E7-F51B019E1CD6Q34130971-1E5149C7-5831-4EF5-97AA-DB1FB2C352ABQ34430949-DFDBB09E-4D1C-44C7-BAC4-9DC953BF0372Q34584404-2B5EE0FA-8344-44BB-B0AA-8B9D8D0F92D2Q34601747-94227CB9-2536-42C6-9CB3-C50D73FD84CFQ35079044-D02A527F-217F-4429-8B20-F0CB2D0068F4Q35098216-819B715A-E847-42F9-8B66-0C93118ECBB5Q35545447-281DFCA3-99AA-4EA2-930F-49B83489EE92Q35590729-090A9389-4164-4F17-911B-02C4A961C671Q35739115-33EB05C2-07A8-44B0-BF7D-19D0D8CEAED0Q35865734-A4CD8EC0-D182-433D-98F0-AF32925935FAQ35866917-6AF1275E-2B35-4C82-A737-1A024C9CBDB8Q35902649-BE907551-0E82-4B97-B23C-0385B5D2B446Q35961275-1D4F7DF8-0289-4308-A98E-E74C0F3D6E67Q36433138-239F87EE-E0F6-48C2-B13E-B8352D93CAEDQ36552347-F4564B15-4BD6-45B8-BCB5-044C35E9FCDBQ36841992-2D3A6635-685F-410B-A63F-3CCA5F919A0CQ36899271-FD4D2AA6-56D4-46FE-B15E-AFCA1AE86712Q37023420-27537707-EB81-49D6-ADAA-EF75F03F028BQ37099445-A1E5C137-8C70-4151-A349-C6026ACC5EC9Q37278891-AB9263EC-6581-42EF-B3F2-FC97E632D80AQ37359630-D54F741F-2E51-4C4C-ABDC-BDC6ADAD33CFQ40096383-6855066C-6294-4CED-92AC-A058F08C46EDQ40128707-094464D4-0A58-4F11-9CDF-30CEA2DE23F0Q46221255-B0F8C952-E16A-496E-9062-0928BD588AFBQ52880344-714BEDB9-0EE1-4995-9A34-F6C03B9A1D5DQ56341766-F6CEA904-C6C8-404D-AE98-AFB5EFD3FF25Q56341991-7E8EA9AF-1E92-4B0D-9A18-172C0D194405Q57488998-1ECEA557-41EE-4970-87FB-128B0CC03AA1
P2860
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@ast
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@en
type
label
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@ast
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@en
prefLabel
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@ast
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@en
P2093
P921
P1433
P1476
Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.
@en
P2093
P304
P577
1999-09-01T00:00:00Z